The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Dalteparin (Fragmin vial) is an anticoagulant ...

FDA Approves Pfizer's and Eisai's FRAGMIN(R) as First Low-Molecular-Weight Heparin for Extended Treatment to Reduce the Recurrence of Blood Clots in Patients with Cancer WOODCLIFF LAKE, N.J. and NEW ...

Eisai Inc, the USA-based subsidiary of the like-named Japanese pharmaceutical major, has signed deal with the world’s largest drugmaker, Pfizer, for exclusive rights to promote its blood-thinning ...

The drug was initially approved by the FDA in 1994 for adults and is a type of heparin. The US Food and Drug Administration has approved Pfizer’s Fragmin (dalteparin sodium) injection to reduce the ...

The US Food and Drug Administration has approved dalteparin sodium (Fragmin; Pfizer) as the first anticoagulant indicated for use in pediatric patients older than 1 month to reduce the risk of ...

The FDA has approved Fragmin, a low molecular weight heparin, for the treatment of symptomatic venous thromboembolism to reduce the recurrence of VTE in pediatric patients 1 month of age and older.

The US Food and Drug Administration (FDA) approved Fragmin (dalteparin sodium) injection, for subcutaneous use, to reduce the recurrence of symptomatic venous thromboembolism (VTE) in paediatric ...

Dalteparin (Fragmin vial) is an anticoagulant (blood thinner) that prevents blood clots in persons undergoing surgery. Along with aspirin Dalteparin (Fragmin vial) is prescribed for heart attack, ...

The FDA has approved Fragmin, a low molecular weight heparin, for the treatment of symptomatic venous thromboembolism to reduce the recurrence of VTE in pediatric patients 1 month of age and older.